Engineering Life: Synbio, Bioethics & Public Policy
Intermediate
Online
3 Weeks
Free Quick Facts
| Medium Of Instructions | Mode Of Learning | Mode Of Delivery |
|---|---|---|
| English | Self Study | Video and Text Based |
Courses and Certificate Fees
| Fees Informations | Certificate Availability | Certificate Providing Authority |
|---|---|---|
| INR 2436 | yes | Coursera |
The Syllabus
Video
- Course Introduction
Reading
- Syllabus: Engineering Life
Videos
- Week 1 Introduction
- A Brief History of rDNA
- A Brief History of Asilomar & the RAC
- Interview: Dr. LeRoy Walters (Part 1)
- Interview: Dr. LeRoy Walters (Part 2)
- Interview: Dr. LeRoy Walters (Part 3)
- Relevant Contemporary Policy Context
- The Emergence of SynBio
Reading
- Week 1 Readings
Practice Exercise
- Week 1 Quiz
Videos
- Week 2 Introduction
- Gain of Function Research
- Dual Use Research
- GOF Research Case Study: H5N1
- Ethical Issues Raised by GOF Research
- Governance and GOF Research
Readings
- Week 2 Readings
- Additional Video Content
Videos
- Week 3 Introduction
- Biofuels
- Applications
- Case Study
- Ethical Issues Raised by SynBio-based Biofuels
- Interview: Deborah Scott, PhD, JD (Part 1)
- Interview: Deborah Scott, PhD, JD (Part 2)
Readings
- Week 3 Readings
- Additional Video Content
Practice Exercise
- Week 3 Quiz
Videos
- Week 4 Introduction
- Synbio in Human Health
- Human Genetic Modification
- Case Study: Artemisinin
- Case Study: GM Mosquitos
- Ethical Issues Raised by SynBio-based Medical Applications
- Governance of SynBio-based Medical Applications
Readings
- Week 4 Readings
- Additional Video Content
Videos
- Week 5 Introduction
- Governance & Engagement in SynBio
- Governance Models
- Public Engagement
- Interview: Dr. LeRoy Walters on Governance and Recombinant DNA
- Interview: Dr. LeRoy Walters on the Importance of Relationships to the Field of SynBio
- Interview: Dr. Jane Calvert (Part 1)
- Interview: Dr. Jane Calvert (Part 2)
Readings
- Week 5 Readings
- Additional Video Content
Instructors
Articles
29 Oct'21, 08:20 AM
29 Oct'21, 08:20 AM